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Abstract Lipid-free human apolipoprotein C-II (apoC-II)
forms amyloid fibrils with characteristic L-structure. This
conformation is distinct from the K-helical fold of lipid-bound
apoC-II. We have investigated the effect of the short-chain
phospholipid, dihexanoylphosphatidylcholine (DHPC) on amy-
loid formation by apoC-II. The K-helical content of apoC-II
increases in the presence of micellar DHPC (16 mM) and
amyloid formation is inhibited. However, at sub-micellar DHPC
concentrations (below 8 mM) amyloid formation is accelerated
6 fold. These results suggest that individual phospholipid
molecules in vivo may exert significant effects on amyloid
folding pathways. ß 2001 Published by Elsevier Science B.V.
on behalf of the Federation of European Biochemical Societies.
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1. Introduction
The primary sequence of mature human apolipoprotein
(apo)C-II, composed of 79 amino acids, contains amphipathic
K-helical regions that account for the increase in K-helical
content upon binding to phospholipid [1,2]. In contrast, lip-
id-free apoC-II aggregates to form L-structure with all of the
characteristics of amyloid ¢brils [3]. In this regard apoC-II is
similar to apoA-I and the C-terminal domain of apoE which
also form amyloid in vitro [4,5]. Apolipoproteins are prevalent
in amyloid deposits in vivo [6,7]. For instance, immunohisto-
chemical studies demonstrate colocalization of apoA-I, apoE
and apoB with amyloid in atherosclerotic plaques [8] while
speci¢c cases exist where apoA-I is the primary component
of atherosclerotic amyloid [9]. These studies suggest a general
propensity of apolipoproteins to form amyloid ¢brils, an
event that may relate to the structural requirements for lipid
binding and the common ancestry of the apolipoprotein fam-
ily [10].
To investigate the role of phospholipid on amyloid forma-
tion by apoC-II we used the short-chain phospholipid dihex-
anoylphosphatidylcholine (DHPC). DHPC has 6-carbon acyl
chains that cause it to behave as a detergent micelle in aque-
ous solution, rather than forming the lipid bilayers character-
istic of longer-chained phospholipids. This allowed an analysis
of the e¡ects of micellar and sub-micellar lipid on amyloid
formation.
2. Materials and methods
2.1. Materials
DHPC was obtained from Avanti Polar Lipids (Alabaster, AL,
USA). ApoC-II was expressed [11] and puri¢ed as described previ-
ously [3] and stored as a stock in 5 M guanidine hydrochloride
(GuHCl) at a concentration of approximately 30 mg/ml. Refolded
apoC-II was prepared by adding sequential aliquots of 50 Wg to 1 ml
of 100 mM sodium phosphate, pH 7.4, at 2 min intervals, to a ¢nal
concentration of 0.3^0.45 mg/ml.
2.2. Spectroscopic analysis
Samples of apoC-II (0.3 mg/ml) containing a range of DHPC con-
centrations from 0 to 16.8 mM were prepared. Emission spectra were
obtained using a SPEX d-2 £uorolog £uorescence spectrometer over
the wavelengths 330^375 nm at 5 nm intervals with excitation at 295
nm using a 0.5 cm quartz cuvette. The excitation and emission slit
widths were 1.89 nm and 5 nm respectively. Circular dichroism (CD)
spectra were recorded at 0.5 nm intervals with a 1 s integration time
and the bandwidth was set at 1.5 nm using an Aviv 62DS CD spec-
trometer with 1 mm pathlength quartz cuvettes. The £uorescence and
CD spectra were corrected by subtracting the spectra of samples con-
taining no apoC-II at the respective DHPC concentrations. Amyloid
formation by apoC-II (0.3 mg/ml) with 0.1% (w/v) sodium azide was
monitored by turbidity measurements at 4 min intervals (Cary-5 spec-
trophotometer, Varian, Australia). Data were corrected for baselines
determined for bu¡er alone. Controls containing no apoC-II indicated
negligible changes in absorbance due to DHPC.
2.3. Analytical ultracentrifugation
Solutions of apoC-II (0.3 mg/ml) with the addition of 0.1% (w/v)
sodium azide were analyzed using the XL-A analytical ultracentrifuge
(Beckman/Coulter). The sedimentation boundaries at di¡erent time
points were analyzed to obtain molecular masses and sedimentation
coe⁄cients using a model for a single sedimenting species [12]. The
partial speci¢c volume (0.732 ml/g) and degree of hydration (0.4 g/g)
for apoC-II were calculated from the amino acid composition [13].
2.4. Electron microscopy
Samples of apoC-II (0.3 mg/ml) in the presence or absence of
DHPC were negatively stained with 2% potassium phosphotungstate
as described [3]. The samples were imaged using a JEOL 2000FX
transmission electron microscope operating at 120 kV. Images were
photographed at a nominal magni¢cation of 60 000U or 80 000U.
3. Results
3.1. Spectroscopic analysis of the interaction of apoC-II with
DHPC
The e¡ect of DHPC on the secondary structure of apoC-II
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was measured by CD spectroscopy (Fig. 1A). Increasing con-
centrations of DHPC caused a systematic decrease in elliptic-
ity in the wavelength range 210^240 nm. The decrease in the
molar ellipticity at 222 nm (Fig. 1B) and the change in the
shape of the spectra in the presence of 16.8 mM DHPC (Fig.
1A) indicated a change from largely unordered structure to a
more ordered, K-helical structure. Addition of increasing con-
centrations of DHPC resulted in a systematic blue shift in the
emission wavelength maxima of the single tryptophan in
apoC-II from 350 to 335 nm. This change was also used to
monitor the e¡ect of DHPC binding (Fig. 1B). The overlay of
the CD and £uorescence data in Fig. 1B suggests that each
method monitors the same conformational event. The sigmoi-
dal titration curve de¢nes a cooperative transition with a mid-
point at approximately 6 mM DHPC. This concentration is
signi¢cantly lower than the values of 10^16 mM reported for
the critical micelle concentration (CMC) of DHPC [14]. Sed-
imentation equilibrium experiments with varying concentra-
tions of DHPC under the conditions used in Fig. 1 yielded
values for the CMC of approximately 8^10 mM (C. MacRaild
and G. Howlett, personal communication). The data in Fig. 1
therefore demonstrate a signi¢cant interaction between apoC-
II and sub-micellar concentrations of DHPC consistent with
either the binding of individual molecules of DHPC to apoC-
II or the induction of DHPC micelle formation by apoC-II.
3.2. Characterization of apoC-II aggregation
Sedimentation velocity pro¢les for apoC-II alone or in the
presence of sub-micellar DHPC (2.8 mM) are presented in
Fig. 2. Initial scans reveal a clearly resolved fast moving
boundary in the presence of 2.8 mM DHPC (Fig. 2B) that
is not evident in the data for apoC-II alone (Fig. 2A). The
rate of movement of the midpoint of this fast moving bound-
ary indicates sedimentation coe⁄cients in excess of 30 S and
in the range reported previously [3]. This rapidly migrating
material accounts for approximately 10% of the optical den-
sity at this wavelength and is depleted from the solution pla-
teau after 40 min of centrifugation. Analysis of the slower
moving boundary over the time interval 50^250 min of sed-
imentation, gave good ¢ts to a single species of molecular
mass close to monomer (Table 1). Sedimentation velocity
data for apoC-II alone (Fig. 2A) over the same time interval
also gave good ¢ts to a single species and a molecular mass
close to monomer (Table 1). These molecular mass values
suggest the predominance of apoC-II monomer (MW 8900)
and the lack of any signi¢cant induction of micelle formation
by apoC-II. For comparison, sedimentation velocity experi-
ments were also performed using micellar concentrations of
DHPC (16.8 mM). The molecular mass obtained under these
conditions (Table 1) is signi¢cantly higher than for apoC-II
alone, consistent with the binding of apoC-II to DHPC mi-
celles.
The fast moving boundary in Fig. 2B suggests that sub-
micellar DHPC promotes amyloid formation by apoC-II. Sed-
imentation velocity experiments were used to characterize the
time course for this process. ApoC-II samples were incubated
at room temperature for 24 h in the presence and absence of
DHPC (2.8 mM). Sedimentation velocity pro¢les for apoC-II
alone (Fig. 2C) show a rapidly moving boundary correspond-
ing to approximately 50% of the total absorbing material and
a slower boundary corresponding to predominantly mono-
meric apoC-II as observed in Fig. 2A. The data shown in
Fig. 2D for apoC-II after 24 h in the presence of DHPC
(2.8 mM) indicate more extensive formation of the fast sed-
imenting species with only minor amounts of slow moving
material.
Electron microscopy was used to further characterize the
aggregates formed by apoC-II in the presence of sub-micellar
DHPC (2.8 mM DHPC). The ¢brils formed in the presence of
2.8 mM DHPC have a ¢brous morphology indistinguishable
to ¢brils formed in the absence of DHPC [3]. There was no
Table 1
E¡ect of DHPC on the molecular mass and sedimentation coe⁄-
cient of apoC-IIa
Addition MW s
None 8 700 (+300, 3300) 0.96 (+0.017, 30.016)
DHPC (2.8 mM) 9 300 (+300, 3300) 1.00 (+0.009, 30.009)
DHPC (16.8 mM) 12 700 (+200, 3200) 1.16 (+0.006, 30.004)
aMolecular masses (MW) and sedimentation coe⁄cients (s) were de-
termined by non-linear least squares analysis of multiple scans at
di¡erent time points using the program SEDFIT [13]. Values in
brackets represent errors calculated using F-statistics with a 68%
con¢dence interval.
Fig. 1. A: DHPC-induced changes in the CD spectrum of apoC-II.
The spectrum of apoC-II (0.3 mg/ml) was measured in the absence
of DHPC (solid line) and in the presence of increasing concentra-
tions of DHPC (2.8 mM ^ long dashed, 5.6 mM ^ medium dashed,
8.4 mM ^ short dashed, 11.2 mM ^ dotted, 14 mM ^ dashed-dot-
ted, 16.8 mM ^ dashed-dotted-dotted). B: DHPC titration of apoC-
II (0.3 mg/ml) monitored by CD and £uorescence emission spectros-
copy. The data are presented as the average molar ellipticity at
220^222 nm (closed circles, dashed line), and the ratio of emission
intensities at 340 and 355 nm upon excitation at 295 nm (open
circles, solid line).
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indication of amorphous material. Parallel samples of apoC-II
were also prepared in the presence of 16.8 mM DHPC. For
these samples, no ¢brillar or amorphous material was ob-
served in repeated grids/samples or of material incubated for
1 week at room temperature, indicating an inhibitory e¡ect of
micellar DHPC on amyloid formation by apoC-II.
3.3. E¡ect of DHPC on amyloid formation by apoC-II
Turbidity measurements were used to monitor the e¡ects of
DHPC on amyloid formation by apoC-II (Fig. 3A). Sub-mi-
cellar concentrations of DHPC (2.8 and 5.6 mM) induce a
more rapid and extensive change in turbidity compared to
the data obtained for apoC-II alone. Conversely, DHPC at
micellar concentrations (s 11 mM) causes a systematic reduc-
tion in the turbidity increase over the same time scale. These
changes in the rate of amyloid formation by apoC-II are sum-
marized by the results in Fig. 3B where the rate of change,
expressed as the change in optical density over the ¢rst 8 h is
plotted as a function of DHPC concentration. The data illus-
trate the acceleration in rate induced by sub-micellar DHPC
and the substantial inhibition observed at DHPC concentra-
tions above the CMC.
4. Discussion
The e¡ect of micellar DHPC on apoC-II aggregation can be
compared with the e¡ect of lipids on other systems known to
form insoluble ¢brils. The Alzheimer’s amyloid peptide AL(1^
40), binds to ganglioside containing membranes with a tran-
sition from random coil to L-sheet, accompanied by acceler-
ated ¢brillogenesis [15]. A similar transformation to L-struc-
ture aggregate is seen when AL(1^40) binds to negatively
charged lipids at low lipid-to-peptide ratios [16]. The neuronal
protein K-synuclein binds to acidic phospholipid vesicles and
undergoes a random coil to K-helical transition [17]. A mutant
form of K-synuclein (A53T), linked to early-onset familial
Parkinson’s disease, shows reduced membrane binding and
more rapid oligomerization kinetics [18]. These results dem-
onstrate that the binding of amyloidogenic peptides and pro-
teins to lipid surfaces can induce secondary structure with the
potential to either increase or decrease the relative rates of
amyloid ¢bril formation.
An unexpected ¢nding of the present work was the en-
hancement of aggregation of apoC-II at sub-micellar DHPC
concentrations (Fig. 3). This was in contrast to the inhibition
observed at micellar concentrations and leads us to propose
the following model (Fig. 4). Under denaturing conditions
apoC-II exists as a random coil (state 1) lacking ordered sec-
ondary structure. Removal of the denaturant generates lipid-
free apoC-II (state 2) characterized by a limited degree of
secondary structure. Lipid-free apolipoproteins in general,
for example apoA-I and the C-terminal domain of apoE,
Fig. 2. Sedimentation velocity analysis of apoC-II (0.3 mg/ml) in the presence and absence of sub-micellar DHPC. For freshly prepared apoC-
II samples (A: apoC-II alone; B: apoC-II in the presence of 2.8 mM DHPC), the ¢rst ¢ve sequential scans were taken at 10 min intervals at a
rotor speed of 40 000 rpm. The 10 subsequent scans were taken at 20 min intervals. Lines through the data represent numerical ¢ts to the data
assuming a single sedimenting species (thick lines). For aliquots of the same samples incubated for 1 day (C: apoC-II alone; D: apoC-II in the
presence of 2.8 mM DHPC), scans were taken at 5 min intervals at a rotor speed of 15 000 rpm.
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have a low energy of stabilization and a loosely de¢ned ter-
tiary structure [19,20]. Such partially folded conformations are
a common characteristic of several proteins that form amyloid
[21,22]. The sedimentation coe⁄cient and molecular mass of
lipid-free apoC-II (Table 1) indicate an extended conforma-
tion characterized by a high axial ratio (4.9) rather than a
value close to unity as expected for a globular conformation.
The model in Fig. 4 proposes that loose, £exible structures,
represented by state 2, account for the time dependent aggre-
gation of apoC-II to form amyloid (state 6). Upon binding to
lipid, apoC-II gains signi¢cant K-helical content (state 3). This
satis¢es the requirements for compact folding with hydrogen-
bound peptide bonds and hydrophobic groups sequestered
from the aqueous environment and with the lipid providing
core structure. According to the model, events that dramati-
cally perturb lipid binding, such as mutations in the case of
apoA-II [6] or truncations in the case of apoA-I [7,9], promote
amyloidosis by preventing compact interaction of the protein
or peptide with lipid. Lipid modi¢cation by enzymes such as
lipoprotein lipase or by oxidation may also favor the amyloid
state relative to lipid binding.
Comparison of Fig. 2A,B with Fig. 2C,D indicates sub-
micellar concentrations of DHPC induce a cooperative and
more extensive polymerization of apoC-II monomers to large
aggregates. This increased aggregation coupled with the lack
of a signi¢cant increase in the molecular mass of slow moving
apoC-II in the presence of sub-micellar DHPC (Table 1) sug-
gests a capacity of apoC-II to interact with individual mole-
cules of DHPC (state 4). CD spectroscopy suggests this inter-
mediate has increased secondary structure (Fig. 1). We
propose that this state has a propensity to aggregate (state
5) and to nucleate amyloid formation (state 6). This would
explain the signi¢cant increase in the rate of amyloid forma-
tion by apoC-II at sub-micellar concentrations of DHPC (Fig.
3). The ability of apoC-II to bind to sub-micellar DHPC
raises the question of whether apoC-II might also bind to
the individual molecules of the longer chain phospholipids
present in vivo. Atherosclerotic plaques contain a necrotic
core that includes free-radical damaged lipids [23] and micel-
lar lipids such as lysolecithin and fatty acids which may also
play a role in nucleating apolipoprotein aggregation. The
common ancestry of the apolipoprotein family and structural
conservation of the class A amphipathic helices suggests that
the results presented here for apoC-II may be generally rele-
vant to the high incidence of apolipoproteins in amyloid re-
lated diseases.
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